Session Recording from PHA's 2010 9th International PH Conference
Left Heart Disease, Obesity and Diastolic Dysfunction
June 27, 2010
The role and prominence of the "left heart" as a cause of pulmonary hypertension will be discussed, as will the contribution of obesity and sleep-disordered breathing to PH. We will also address clinical clues and non-invasive testing, such as echo-doppler, that can help differentiate the "left heart" patient from patients with pulmonary vascular disease.
View session handout (PDF)
The below recording will begin automatically. To view the controls, move your mouse anywhere over the video then move to the control interface at the bottom of the video.
|
Presenter Information
|
-Paul Forfia, MD, Hospital of University of Pennsylvania, Philadelphia, Penn. (chair)
-Francois Haddad, MD, Stanford University, Stanford, Calif.
-Ronald Oudiz, MD, Harbor-UCLA Medical Center, Torrance, Calif.
-Joan Zhang, CRNP, MSN; University of Pittsburgh, Pittsburgh, Penn. |
|
DIAMOND
SUPPORTER
|
PLATINUM
SUPPORTER
|
GOLD
SUPPORTER
|
SILVER
SUPPORTER
|
| Actelion Pharmaceuticals US, Inc. |
Gilead Sciences, Inc. |
United Therapeutics Corporation |
Bayer HealthCare |
This is a program of the PHA Medical Education Fund, made possible through unrestricted educational grants from our supporters.